Free Download Brochure for

SmartPRep2 – APC and BMAC

More Downloads

Technology Platforms

TRICell, being pioneers in the field of stem cell therapy, is well positioned to evolve impeccably efficient processing mechanisms that ensure the highest yield and potency, maximizing the benefits that processed bioactive components can deliver when used in treatment. It aims to simplify stem cell procurement life cycle and provide unparalleled consistency and reproducibility to those using its ultimate products to advance the understanding of crucial diseases. Every client who is associated with TRICell enjoys the privilege of being at the edge of innovation as a result of TRICell’s inclination towards adopting the industry’s leading technological platforms, industry collaborations and engineering breakthroughs.

The Autologous Advantage

TRICell’s technology adoption revolves exclusively around adult stem cells and autologous bioactive products derived from and administered to the same patient. Autologous end products reduce the risk of rejection and increase the likelihood of integration with the surrounding tissues, eliminating the need for immunosuppressive drugs.

SMARTPREP 2 SYSTEM